QuadMedicine, Inc. (KOSDAQ:464490)
South Korea · Delayed Price · Currency is KRW 4,200.00
+165.00 (4.09%)
At close: Oct 16, 2026
QuadMedicine Market Cap
QuadMedicine has a market cap or net worth of 48.22 billion as of October 16, 2026. It is the 32,989th most valuable company in the world and the 1,865th biggest in South Korea.
Market Cap
48.22B
Enterprise Value
38.97B
Revenue
7.14B
Global Rank
Country Rank
#1,865 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 12, 2025, QuadMedicine's market cap has decreased from 199.95B to 48.22B, a decrease of -75.88%. That is a compound annual growth rate of -81.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 48.22B | -72.73% |
| Dec 30, 2025 | 176.81B | -11.57% |
| Dec 12, 2025 | 199.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PanGen Biotech | 64.26B |
| ABION | 60.91B |
| ADBiotech | 58.08B |
| Psomagen | 56.36B |
| TegoScience | 55.09B |
| NovMetaPharma | 54.06B |
| KoBioLabs | 53.40B |
| J2KBIO | 50.29B |